{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:29:03Z","timestamp":1793806143004,"version":"4.6.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20251552"],"award-info":[{"award-number":["20251552"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This retrospective observational study evaluated the incidence, subtypes, and risk factors for hemorrhagic transformation (HT) after tenecteplase\u2013tissue plasminogen activator (TNK-tPA) therapy in patients with acute ischemic stroke. Adults with acute ischemic stroke who received intravenous TNK-tPA between June 2022 and June 2025 and had complete baseline data and follow-up neuroimaging were included. All patients underwent routine follow-up computed tomography or magnetic resonance imaging at 24\u2005\u00b1\u20056 hours after thrombolysis, with additional earlier imaging when neurological deterioration occurred. Demographic characteristics, vascular risk factors, baseline neurological severity assessed by the National Institutes of Health Stroke Scale, blood pressure, pre-stroke antiplatelet use, onset-to-needle time, Alberta Stroke Program Early CT Score, and admission laboratory parameters \u2013 including white blood cell count, hemoglobin, platelet count, international normalized ratio, fibrinogen, and D-dimer (mg\/L fibrinogen-equivalent units) \u2013 were collected. HT was classified as hemorrhagic infarction (HI-1, HI-2) or parenchymal hematoma (PH-1, PH-2) according to European Cooperative Acute Stroke Study criteria. Among 181 TNK-tPA-treated patients, 28 (15.5%) developed HT, including 17 cases of HI and 11 of PH. In an exploratory multivariable logistic regression model, older age, higher baseline National Institutes of Health Stroke Scale, lower Alberta Stroke Program Early CT Score, higher systolic blood pressure, and increased international normalized ratio and D-dimer levels were associated with HT. The model showed acceptable apparent calibration and discrimination (area under the receiver operating characteristic curve\u2005=\u20050.86); however, 14 candidate variables were evaluated for only 28 events (approximately 2 events per variable), creating a substantial risk of overfitting. These findings are hypothesis-generating and require validation in larger independent cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050666","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:13Z","timestamp":1790359273000},"page":"e50666","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for hemorrhagic transformation after tenecteplase therapy in acute ischemic stroke"],"prefix":"10.1097","volume":"105","author":[{"given":"Xiaoxuan","family":"Wang","sequence":"first","affiliation":[{"name":"The Second Department of Cerebrovascular Disease, Cangzhou Central Hospital, Cangzhou, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyue","family":"Huang","sequence":"additional","affiliation":[{"name":"The Second Department of Cerebrovascular Disease, Cangzhou Central Hospital, Cangzhou, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Department of Cerebrovascular Disease, Cangzhou Central Hospital, Cangzhou, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Neurophysiology, Cangzhou Central Hospital, Cangzhou, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6383-4184","authenticated-orcid":false,"given":"Zhen","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Neurovascular Intervention, Cangzhou Central Hospital, Cangzhou, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1474-4422(24)00377-6","article-title":"Tenecteplase versus alteplase for acute stroke within 4 5\u2009h of onset (ATTEST-2): a randomised, parallel group, open-label trial.","volume":"23","author":"Muir","year":"2024","journal-title":"Lancet Neurol"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"e031692","DOI":"10.1161\/JAHA.123.031692","article-title":"Comprehensive review of tenecteplase for thrombolysis in acute ischemic stroke.","volume":"13","author":"Wang","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s40001-023-01503-x","article-title":"Prediction factors and clinical significance of different types of hemorrhagic transformation after intravenous thrombolysis.","volume":"28","author":"Hao","year":"2023","journal-title":"Eur J Med Res"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"1079205","DOI":"10.3389\/fneur.2023.1079205","article-title":"Risk factors of hemorrhagic transformation in acute ischaemic stroke: a systematic review and meta-analysis.","volume":"14","author":"Sun","year":"2023","journal-title":"Front Neurol"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/qjmed\/hcy292","article-title":"Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction.","volume":"112","author":"Wang","year":"2019","journal-title":"QJM"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.wneu.2017.01.091","article-title":"Risk factors for hemorrhagic transformation after intravenous thrombolysis in acute cerebral infarction: a retrospective single-center study.","volume":"101","author":"Xu","year":"2017","journal-title":"World Neurosurg"},{"key":"R8-20261104","first-page":"5542","article-title":"Hemorrhagic risk factors after rt PA thrombolysis in acute cerebral infarction.","volume":"27","author":"Liu","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41440-025-02404-8","article-title":"Development of tenecteplase for stroke thrombolysis: Japan\u2019s endeavor.","volume":"49","author":"Toyoda","year":"2025","journal-title":"Hypertens Res"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s41983-024-00885-x","article-title":"Analysis of predictors of hemorrhagic transformation after reperfusion therapy with recombinant tissue plasminogen activator in patients with acute ischemic stroke: a single-center experience.","volume":"60","author":"Nassar","year":"2024","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s13311-023-01377-1","article-title":"Hemorrhagic conversion of acute ischemic stroke.","volume":"20","author":"Zubair","year":"2023","journal-title":"Neurotherapeutics"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1136\/jnis-2022-019719","article-title":"Emergency admission plasma D-dimer: a novel predictor for symptomatic intracranial hemorrhage after thrombectomy in acute ischemic stroke.","volume":"15","author":"Qiu","year":"2023","journal-title":"J Neurointerv Surg"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"10760296241310438","DOI":"10.1177\/10760296241310438","article-title":"The D-Dimer\/albumin ratio as a novel biomarker for predicting the efficacy of oral tirofiban in patients with cerebral infarction.","volume":"31","author":"Li","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"1466543","DOI":"10.3389\/fneur.2025.1466543","article-title":"Prediction of hemorrhagic transformation after thrombolysis based on machine learning models combined with platelet distribution width-to-count ratio.","volume":"16","author":"Li","year":"2025","journal-title":"Front Neurol"},{"issue":"7_supplement_1","key":"R15-20261104","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1212\/WNL.0000000000205474","article-title":"Tale of two thrombolytics: alteplase vs. tenecteplase \u2013 hemorrhagic transformation in acute ischemic stroke (P8-5.001).","volume":"102","author":"Caicedo","year":"2024","journal-title":"Neurology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:01:12Z","timestamp":1793804472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050666"}},"subtitle":["A retrospective observational study"],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":15,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050666","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2025-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}